In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
All content for Genetic Sounds is the property of The European Society of Human Genetics and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
E2 - Treatments of Genetic Conditions and their Costs
Genetic Sounds
45 minutes
2 years ago
E2 - Treatments of Genetic Conditions and their Costs
In this episode, we discuss the treatments of genetic conditions, exciting breakthroughs, and their costs. A conversation with Assistant Professor Roos van Westrhenen, Professors Katherine Payne and Graeme Black from the University of Manchester, and Wayne Thompson, a patient who took part in a gene therapy trial for Choroideremia.
Genetic Sounds
In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
